Terns Pharmaceuticals Appoints Scott Harris as Chief Development Officer and Announces Departure of Erin Quirk, M.D., President, Head of Research and Development
Position
Chief Development Officer
Company
Terns Pharmaceuticals
Description
Terns Pharmaceuticals, Inc. has appointed Scott Harris as chief development officer (CDO) effective May 28, 2024, and announced the upcoming departure of Erin Quirk, M.D., president, head of research and development, who will be leaving the company effective June 3, 2024. Mr
Quick answer
Terns Pharmaceuticals Appoints Scott Harris as Chief Development Officer and Announces Departure of Erin Quirk, M.D., President, Head of Research and Development (May 8, 2024). Terns Pharmaceuticals is based in Foster City, California, United States.
- What did Terns Pharmaceuticals announce on May 8, 2024?
- Terns Pharmaceuticals, Inc. has appointed Scott Harris as chief development officer (CDO) effective May 28, 2024, and announced the upcoming departure of Erin Quirk, M.D., president, head of research and development, who will be leaving the company effective June 3, 2024.
- What does Terns Pharmaceuticals do?
- Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology, obesity and NASH.
- Where is Terns Pharmaceuticals based?
- Terns Pharmaceuticals is based in Foster City, California, United States.
- Which similar companies made leadership changes around the same time?
- Crinetics Pharmaceuticals (May 30, 2024), OnKure Therapeutics (June 19, 2024), AbbVie Inc. (June 20, 2024) and EyePoint, Inc. (May 9, 2024) also announced leadership changes within 45 days of Terns Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D. as Senior Vice President of Medical Affairs (May 30, 2024)
- OnKure, Inc. Appoints Rogan Nunn as General Counsel and Secretary (June 19, 2024)
- AbbVie Appoints Roxanne S. Austin as Lead Independent Director (June 20, 2024)
- EyePoint Pharmaceuticals, Inc. Appoints Isabelle Lefebvre as Chief Regulatory Officer (May 9, 2024)
- YS Biopharma Appoints Dave Chenn as Interim CEO and Hui Shao as Co-CEO and CBO (May 7, 2024)
- Pfizer Inc. names Andrew Baum as Chief Strategy and Innovation Officer, Executive Vice President (May 6, 2024)
Who to call at Terns Pharmaceuticals, and when
A new leader at Terns Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Terns Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Terns Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Terns Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Terns Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Terns Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.